BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 29702641)

  • 1. RosettaAntibodyDesign (RAbD): A general framework for computational antibody design.
    Adolf-Bryfogle J; Kalyuzhniy O; Kubitz M; Weitzner BD; Hu X; Adachi Y; Schief WR; Dunbrack RL
    PLoS Comput Biol; 2018 Apr; 14(4):e1006112. PubMed ID: 29702641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new clustering of antibody CDR loop conformations.
    North B; Lehmann A; Dunbrack RL
    J Mol Biol; 2011 Feb; 406(2):228-56. PubMed ID: 21035459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
    Kuroda D; Shirai H; Kobori M; Nakamura H
    Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-constraint computational design suggests that native sequences of germline antibody H3 loops are nearly optimal for conformational flexibility.
    Babor M; Kortemme T
    Proteins; 2009 Jun; 75(4):846-58. PubMed ID: 19194863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diversity of H3 loops determines the antigen-binding tendencies of antibody CDR loops.
    Tsuchiya Y; Mizuguchi K
    Protein Sci; 2016 Apr; 25(4):815-25. PubMed ID: 26749247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational design of protein antigens that interact with the CDR H3 loop of HIV broadly neutralizing antibody 2F5.
    Azoitei ML; Ban YA; Kalyuzhny O; Guenaga J; Schroeter A; Porter J; Wyatt R; Schief WR
    Proteins; 2014 Oct; 82(10):2770-82. PubMed ID: 25043744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do antibody CDR loops change conformation upon binding?
    Liu C; Denzler LM; Hood OEC; Martin ACR
    MAbs; 2024; 16(1):2322533. PubMed ID: 38477253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.
    Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A
    Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting antibody complementarity determining region structures without classification.
    Choi Y; Deane CM
    Mol Biosyst; 2011 Dec; 7(12):3327-34. PubMed ID: 22011953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Analysis of the CDR Loops of Antigen Receptors.
    Wong WK; Leem J; Deane CM
    Front Immunol; 2019; 10():2454. PubMed ID: 31681328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
    Wu H; Nie Y; Huse WD; Watkins JD
    J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-scale sequence and structural comparisons of human naive and antigen-experienced antibody repertoires.
    DeKosky BJ; Lungu OI; Park D; Johnson EL; Charab W; Chrysostomou C; Kuroda D; Ellington AD; Ippolito GC; Gray JJ; Georgiou G
    Proc Natl Acad Sci U S A; 2016 May; 113(19):E2636-45. PubMed ID: 27114511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational Tools for Aiding Rational Antibody Design.
    Krawczyk K; Dunbar J; Deane CM
    Methods Mol Biol; 2017; 1529():399-416. PubMed ID: 27914064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational sampling of CDR-H3 in antibodies by multicanonical molecular dynamics simulation.
    Shirai H; Nakajima N; Higo J; Kidera A; Nakamura H
    J Mol Biol; 1998 May; 278(2):481-96. PubMed ID: 9571065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homology Modeling of Antibody Variable Regions: Methods and Applications.
    Bansia H; Ramakumar S
    Methods Mol Biol; 2023; 2627():301-319. PubMed ID: 36959454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDR-H3 diversity is not required for antigen recognition by synthetic antibodies.
    Persson H; Ye W; Wernimont A; Adams JJ; Koide A; Koide S; Lam R; Sidhu SS
    J Mol Biol; 2013 Feb; 425(4):803-11. PubMed ID: 23219464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AbDesign: An algorithm for combinatorial backbone design guided by natural conformations and sequences.
    Lapidoth GD; Baran D; Pszolla GM; Norn C; Alon A; Tyka MD; Fleishman SJ
    Proteins; 2015 Aug; 83(8):1385-406. PubMed ID: 25670500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of flexible backbone protein design methods for sequence library prediction in the therapeutic antibody Herceptin-HER2 interface.
    Babor M; Mandell DJ; Kortemme T
    Protein Sci; 2011 Jun; 20(6):1082-9. PubMed ID: 21465611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OptCDR: a general computational method for the design of antibody complementarity determining regions for targeted epitope binding.
    Pantazes RJ; Maranas CD
    Protein Eng Des Sel; 2010 Nov; 23(11):849-58. PubMed ID: 20847101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humanization by CDR grafting and specificity-determining residue grafting.
    Kim JH; Hong HJ
    Methods Mol Biol; 2012; 907():237-45. PubMed ID: 22907355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.